OVID Ovid Therapeutics Inc

Ovid Therapeutics Inc is a US-based biopharmaceutical company. The firm is engaged primarily in developing medicines for patients suffering with rare neurological disorders.

As of 12/02/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/05/2017
Outstanding shares:  70,466,885
Average volume:  64,329
Market cap:   $127,545,062
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYPFK63
Valuation   (See tab for details)
PE ratio:   -1.76
PB ratio:   0.77
PS ratio:   68.49
Return on equity:   -116.36%
Net income %:   -10,309.14%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy